These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 17342308

  • 21. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 22. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M.
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [Abstract] [Full Text] [Related]

  • 23. Expression of mucin core protein of mammary type in primary liver cancer.
    Sasaki M, Nakanuma Y.
    Hepatology; 1994 Nov; 20(5):1192-7. PubMed ID: 7523272
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
    Chiaramondia M, Ceppa P, Baccini P, Badini A, Castellaneta A.
    Pathologica; 1993 Nov; 85(1100):687-99. PubMed ID: 8170717
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
    Kilpatrick SE, Geisinger KR, Loggie BW, Hopkins MB.
    Acta Cytol; 1993 Nov; 37(6):943-7. PubMed ID: 7504382
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G.
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [Abstract] [Full Text] [Related]

  • 35. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    J Gastrointest Surg; 2006 May; 10(7):987-98. PubMed ID: 16843869
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C, Herlea V, Dragnea A, Popescu I.
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D, Kagata Y, Ogata S, Tsuda H, Hatsuse K, Mochizuki H, Matsubara O.
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M.
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.